Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-06 | Mr. Mark H. NawackiIndependent Director | 10,00k | 0,00 | Kauf | - | 25,00k | 66,67% |
| 2026-04-02 | Mr. Francis GleesonCo-Founder, CEO, President & Director | 108,63k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 624,94k | 21,04% |
| 2026-04-02 | Ms. Antoinette PaoneChief Development Officer & Head of Regulatory Affairs | 26,86k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 104,16k | 34,75% |
| 2026-04-02 | Dr. Philip LambertChief Scientific Officer | 36,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 234,13k | 18,30% |
| 2026-04-02 | Dr. Wildon FarwellChief Medical Officer | 54,31k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 208,31k | 35,27% |
| 2026-04-02 | Ms. Elizabeth WilliamsCFO & Corporate Secretary | 36,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 208,31k | 21,04% |
| 2026-04-02 | Dr. Michael A. RudnickiCo-Founder & Chief Discovery Officer | 36,66k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,93 | 260,39k | 16,39% |
| 2026-03-12 | Mr. Mark H. NawackiIndependent Director | 15,00k | 0,00 | Kauf | - | 15,00k | - |
| 2026-01-30 | Mr. Francis GleesonCo-Founder, CEO, President & Director | -5,68M | 0,00 | Other Derivative Disposition | - | 516,31k | -91,67% |
| 2026-01-30 | Dr. Michael A. RudnickiCo-Founder & Chief Discovery Officer | -2,46M | 0,00 | Other Derivative Disposition | - | 223,73k | -91,67% |
| 2026-02-09 | Mr. Franklin M. BergerIndependent Director | 24,75k | 249,98k | Kauf | 10,10 | 681,33k | 3,77% |
| 2026-01-30 | Mr. Franklin M. BergerIndependent Director | -205,12k | 0,00 | Other Derivative Disposition | - | 18,65k | -91,67% |
| 2026-01-30 | Mr. Geoff MacKayIndependent Chairman of the Board of Directors | -504,05k | 0,00 | Other Derivative Disposition | - | 45,82k | -91,67% |
| 2026-01-30 | Ms. Elizabeth WilliamsCFO & Corporate Secretary | -1,89M | 0,00 | Other Derivative Disposition | - | 172,10k | -91,67% |
| 2026-01-30 | Mr. Adam S. MostafaIndependent Director | -250,91k | 0,00 | Other Derivative Disposition | - | 22,81k | -91,67% |
| 2026-01-30 | Dr. Selwyn HoIndependent Director | -202,83k | 0,00 | Other Derivative Disposition | - | 18,44k | -91,67% |
| 2026-01-30 | Dr. Wildon FarwellChief Medical Officer | -1,69M | 0,00 | Other Derivative Disposition | - | 154,00k | -91,67% |
| 2026-01-30 | Dr. Philip LambertChief Scientific Officer | -2,18M | 0,00 | Other Derivative Disposition | - | 197,92k | -91,67% |
| 2026-01-30 | Ms. Stephanie BrownIndependent Director | -205,72k | 0,00 | Other Derivative Disposition | - | 18,70k | -91,67% |
| 2026-01-30 | Dr. Iris Low-FriedrichIndependent Director | -202,83k | 0,00 | Other Derivative Disposition | - | 18,44k | -91,67% |
| 2026-01-22 | Ms. Antoinette PaoneChief Development Officer & Head of Regulatory Affairs | 6,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 111,65 | 6,44k | - |
| 2025-11-14 | Mr. Mark H. NawackiIndependent Director | 18,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,91 | 18,44k | - |
| 2025-09-13 | Mr. Francis GleesonCo-Founder, CEO, President & Director | -10,42k | 0,00 | Other Derivative Disposition | 5,20 | 0,00 | -100,00% |
| 2025-09-13 | Mr. Brian Matthew BloomIndependent Director | -20,83k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-09-13 | Bloom Burton Investment Group Inc.Unternehmen | -42,29k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-08-15 | Dr. Wildon FarwellChief Medical Officer | 154,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 5,04 | 154,00k | - |
| 2025-06-18 | Dr. Selwyn HoIndependent Director | 18,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 18,44k | - |
| 2025-06-18 | Dr. Iris Low-FriedrichIndependent Director | 18,44k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 18,44k | - |
| 2025-06-18 | Mr. Franklin M. BergerIndependent Director | 9,22k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 18,65k | 97,80% |
| 2025-06-18 | Mr. Geoff MacKayIndependent Chairman of the Board of Directors | 9,22k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 45,82k | 25,19% |
| 2025-06-18 | Mr. Adam S. MostafaIndependent Director | 9,22k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 22,81k | 67,84% |
| 2025-06-18 | Ms. Stephanie BrownIndependent Director | 9,22k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,82 | 18,70k | 97,24% |
| 2025-05-14 | Bloom Burton Investment Group Inc.Unternehmen | -1,64M | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
